Haemonetics Corp
NYSE:HAE
Wall Street
Price Targets
HAE Price Targets Summary
Haemonetics Corp
According to Wall Street analysts, the average 1-year price target for
HAE
is 93.84 USD
with a low forecast of 74.74 USD and a high forecast of 113.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HAE's stock price target?
Price Target
93.84
USD
According to Wall Street analysts, the average 1-year price target for
HAE
is 93.84 USD
with a low forecast of 74.74 USD and a high forecast of 113.4 USD.
What is Haemonetics Corp's Revenue forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Haemonetics Corp's revenue is
5%.
The projected
CAGR
for the next 3 years is
4%.
What is Haemonetics Corp's Operating Income forecast?
Projected CAGR
20%
For the last 13 years the
compound annual growth rate for
Haemonetics Corp's operating income is
7%.
The projected
CAGR
for the next 3 years is
20%.
What is Haemonetics Corp's Net Income forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Haemonetics Corp's net income is
7%.
The projected
CAGR
for the next 3 years is
19%.
